Geneos Therapeutics snags $10.5 mln Series A
Pennsylvania-based Geneos Therapeutics, a developer of cancer therapies, has raised $10.5 million in Series A funding. Santé Ventures led the round with participation from Inovio.
21 February 2019•1 min read
